Correlation of myocardial interstitial collagen in the right ventricular septum with ventricular function of patients with ischemic cardiomyopathy;Correlação do colágeno intersticial miocárdico do septo do ventrículo direito com a função ventricular em pacientes com cardiomiopatia isquêmica

Arquivos Brasileiros de Cardiologia

Volumn 92, Issue 1, 2009, Pages 52-60

  Montera, Marcelo Westerlund ^a,b,c,g   Drumond, Cantídio ^e   Takiya, Cristina ^f   Mesquita, Cláudio Tinoco ^c   Dohmann, Hans Fernando R ^d   Mady, Charles ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL PRÓ CARDÍACO   (Brazil)

^c Laboratório de Medicina Nuclear   (Brazil)

^d Laboratório de Cateterismo Cardíaco   (Brazil)

^e Santa Casa de Misericordia de Goiania   (Brazil)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g NONE   (Brazil)

Author keywords

Cardiac output, low; Collagen; Myocardial ischemia; Ventricular function, left; Ventricular function, right

Indexed keywords

ATENOLOL; CAPTOPRIL; CARVEDILOL; COLLAGEN; DIGOXIN; ENALAPRIL; NITRATE; PERTECHNETIC ACID TC 99M; PROPRANOLOL DERIVATIVE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOMYOPATHY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE SEPTUM; HUMAN; HUMAN TISSUE; MALE; QUANTITATIVE ANALYSIS; SCINTIANGIOGRAPHY; STAINING; EPIDEMIOLOGY; HEART STROKE VOLUME; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

COLLAGEN; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR SEPTUM;

EID: 60749128078     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2009000100009     Document Type: Article

References (49)

1. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998; 97: 282-9.
2. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in Collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation. 2001; 104: 2996-3007.
3. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002; 347: 1397-402.
4. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000; 342: 1077-84.
5. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol. 1987; 59: 634-8.
6. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983; 51: 831-6.
7. Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 1997; 30: 1002-8.
8. Volders PGA, Willems IE, Cleutjens JP, Arends JW, Havenith MG, Daemen MJ. Interstitial collagen is increased in the noninfarcted myocardium after myocardial infarction. J Mol Cell Cardiol. 1993; 25: 1317-23.
9. Wei S, Chow LT, Schum IO, Chin L, Sanderson JE. . Left and right ventricular collagen type I/III ratio and remodeling post-myocardial infarction. J Card Fail. 1999; 5: 117-26.
10. Cooper GIV. Basic determinants of myocardial hypertrophy: a review of molecular mechanisms. Annu Rev Med. 1997; 48: 13-23.
11. Iwai N, Shimoike H, Kinoshita M. Genes up-regulated in hypertrophied ventricle. Biochem Biophys Res Commun. 1995; 209: 527-34.
12. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cígola E, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994; 89: 151-63.
13. Schaper J, Froede R, Hein ST, Buck A, Hashizume H, Speiser B, et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991; 83: 504-14.
14. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Circulation. 1991; 83: 1849-65.
15. Litwin SE, Litwin CM, Raya TE, Warner AL, Goldman S. Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats: effects of chronic angiotensin converting enzyme inhibition. Circulation. 1991; 83: 1028-37.
16. Hare JM, Walford GD, Hruban RH, Hutchins GM, Deckers JW, Baughman KL. Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease. J Am Coll Cardiol. 1992; 20: 1318-25.
17. Port SC. Imaging guidelines for nuclear cardiology procedures. Part II. American Society of Nuclear Cardiology. J Nucl Cardiol. 1999; 6: G47-84.
18. Berger HJ, Gottschalk A, Zaret BL. First-pass radionuclide angiocardiography for evaluation of right and left ventricular performance: computer applications and technical considerations. In: Sorenson JA (ed). Nuclear cardiology: selected computer aspects. New York: Society of Nuclear Medicine; 1978. p. 29-44.
19. Callahan RJ, Froelich JW, Mckusick KA, Leppo J, Strauss HW. A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication. J Nucl Med. 1982; 23: 315-8.
20. Mason JW. Techniques for right and left ventricular endomyocardial biopsy. Am J Cardiol. 1978; 41: 887-92.
21. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res. 1991; 69: 107-15.
22. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res. 1990; 67: 1355-64.
23. Doering CW, Jalil JE, Janicki JS, Pick R, Aghili S, Abrahams C, et al. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res. 1988; 22: 686-95.
24. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991; 83: 1771-9.
25. Pauschinger M, Knopf D, Petschauer S, Doerner A, Poller W, Schwimmbeck PL, et al. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation. 1999; 99: 2750-6.
26. Mukherjee D, Sen S. Alteration of collagen phenotypes in ischemic cardiomyopathy. J Clin Invest. 1991; 88: 1141-6.
27. Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC Jr, Cruickshank JM, et al. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol. 1992; 20: 3-16.
28. Zisman LS,Asano K,Dutcher DL, Ferdensi A, Robertson AD, Jenkin M, et al. Differential regulation of cardiac angiotensin converting enzyme binding sites and AT1 receptor density in the failing human heart. Circulation. 1998; 98: 1735-41.
29. Bishop JE, Greenbaum R, Gibson DG, Yacoub M, Laurent GJ. Enhanced deposition of predominantly type I collagen in myocardial disease. J Mol Cell Cardiol. 1990; 22: 1157-65.
30. Brooks A, Schinde V, Bateman AC, Gallagher PJ. Interstitial fibrosis in the dilated non-ischaemic myocardium. Heart. 2003; 89: 1255-6.
31. Karsch KR, Kreuzer H, Neuhaus KL. Myocardial function of the right ventricle in coronary disease. Z Kardiol. 1976; 65 (11): 972-82.
32. La Vecchia L, Luca Spadaro G, Paccanaro M, Favero L, Zanolla L, Vincenzi P, et al. Predictors of right ventricular dysfunction in patients with coronary artery disease and reduced left ventricular ejection fraction. Coron Artery Dis. 2002; 13 (6): 319-22.
33. Hess OM, Schneider J, Koch R, Bamert C, Crimm J, Krayenbuehl HP. Diastolic function and myocardial structure in patients with myocardial hypertrophy: special reference to normalized viscoelastic data. Circulation. 1981; 63: 360-71.
34. Pelouch V, Dixon IMC, Golfman L, Beamish RE, Dhalla NS. Role of extracellular matrix proteins in heart function. Mol Cell Biochem. 1993; 129: 101-20.
35. Smits JFM, Van Krimpen C, Schoemaker RG, Cleutjens JP, Daemen MJ. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol. 1992; 20: 772-8.
36. Pfeffer JM, Pfeffer MA, Fishbein MC, Frohlich ED. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol. 1979; 6: H461-8.
37. Klappacher G, Franzen P, Haab D, Mehrabi M, Binder M, Plesch K, et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol. 1995; 175 (14): 913-8.
38. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation. 2000; 102: 1388-93.
39. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metanalysis of 109 treatment studies. Am J Hypertens. 1992; 5: 95-110.
40. Diez R, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago JL. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left-ventricular chamber stiffness in hypertensive patients. Circulation. 2002; 105: 2512-7.
41. Marijianowski MMH, Teeling P, Becker A. Remodeling after myocardial infarction in humans is not associated with intersticial fibrosis of noninfarcted myocardium. J Am Coll Cardiol. 1997; 30: 76-82.
42. Volders PGA, Daemen MJAP. Interstitial fibrosis and angiotensin- converting enzyme inhibition in patients with end-stage myocardial infarction. (letter). J Am Coll Cardiol. 1998; 32: 552.
43. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992; 327: 669-77.
44. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left-ventricular ejection fractions: the SOLVD Investigators. N Engl J Med. 1992; 327: 685-91.
45. Pitt B, Zanna F, Remm WJ, Cody R, Castaigne A, Perez A, et al. for The Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999; 341: 709-17.
46. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. The Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterona blocker in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003; 348: 1309-21.
47. Hayashi M, Tsutamoto T, Wada A, Tsutsui T, Ishii C, Ohno K, et al. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents postinfarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation. 2003; 107: 2559-65.
48. Pickering JG, Boughner DR. Fibrosis in the transplanted heart and its relation to donor ischemic time. Circulation. 1990; 80: 949-58.
49. Chello M, Mastroroberto P, Romano R, Perticone F, Marchese AR. Collagen network remodeling and left ventricular function in constrictive pericarditis. Heart. 1996; 75: 184-9.